A synthetic poly(styrene-maleic anhydride) copolymer of average molecular weight 470000 potentiated a testosterone-binding antibody response during immunization of sheep with immunogenic testosterone-3-carboxymethyloxime-serum albumin conjugates.
Introduction
Immunization of animals against steroid hormones can result in physiological changes, some of which have practical significance to animal production (Nieschlag and Wickings 1978) . Thus passive or active immunization of the ewe against steroids can increase ovulation rate and fecundity (Cox et al. 1982; Scaramuzzi and Hoskinson 1984) . Significantly, this progress with active steroid immunization has been due to the introduction of the immunoadjuvant DEAE-dextran to the field (Cox and Wilson 1976) as an alternative to Freund's complete adjuvant (FCA).
Nevertheless, there remains a considerable interest in alternative adjuvants because of their potential to influence the magnitude and persistence of the antibody response, as well as the associated ovulation rate response in steroid-immune ewes.
Polyanions have been found to enhance specific humoral immune responses when administered to animals together with immunogen; at the level of the lymphocyte this effect appears to be achieved by their ability to replace thymus cell function partiy, but additionally, by an ability to enhance bone marrow cell memory (Kaplan et al. 1978) . Previous studies with polycarboxylic polyanions or their closely related anhydrides (Brown et al. 1970; Diamanstein et al. 1971; Wieczorek et al. 1975 ) have been concerned with antibodies to red blood cell antigens and they provide no direct information about antibody to hormonal hapten.
Reported here is a study comprising four experiments in sheep to explore the immunoadjuvant properties of a synthetic styrene-maleic anhydride copolymer similar to that introduced by Wieczorek et al. (1975) for rodents. The present studies were designed to determine, with testosterone as a model hapten, whether the copolymer could stimulate antihapten antibody in the sheep and, if so, to ascertain the magnitude and temporal characteristics of the antibody responses. Using the optimal treatment conditions devised, the ovulatory response in a group of 20 testosterone-immune Merino ewes has been compared to 20 untreated control animals.
Materials and Methods

General Reagents
Chemicals used were: polyethylene glycol 6000 (PEG, B.D.H. Chemicals); bovine serum albumin (BSA, Fraction V, Commonwealth Serum Laboratories); human serum albumin (HSA, Fraction V, Calbiochem) and bovine gammaglobulin (B'YG, Calbiochem); gelatin (Sigma); l-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (Sigma); FCA and Incomplete Freund's Adjuvant (IFA, Difco Laboratories); Bordetella pertussis vaccine (Commonwealth Serum Laboratories); [I,2,6,7(n) _3H]-testosterone, specific activity 3·44 TBq/mmol (Radiochemical Centre, Amersham, England); 'gelatin buffer' consisted of phosphate (0·05 M, pH 7 ·4) containing gelatin (0·1 % w/v), sodium azide (0·1 % w/v) and sodium chloride (0·9% w Iv). Scintillation solutions contained 0·3% (w Iv) p-terphenylbenzene and 0·01 % (w/v) [I,4-bis-(5-phenyloxazol-2-yl)-benzene] in toluene. All other chemicals were Analar grade and glassdistilled water was used for all solutions.
Preparation of Antigens
Separate conjugates of testosterone-3-carboxymethyloxime and serum albumin were prepared for each experiment. Testosterone-3-0-carboxymethyloxime (T-3-CMO) was synthesized by the method of Erlanger et al. (1967) and conjugated with BSA or HSA in a similar procedure to that of Lindner et al. (1972) using l-ethyl-3-(3-dimethylaminopropyl) carbodiimide in dioxan-phosphate buffer. The products were dialysed (4°C) against dioxan-water, phosphate buffer, and water. The retentate was lyophilized to yield either the BSA or HSA conjugate of T-3-CMO as a white powder. By using radiolabelled steroid the testosterone incorporation was found to be 18-20 moles per mole of serum albumin.
Animals
Corriedale ewes (93), Merino wethers (18) and Merino ewes (40) aged 2-5 years were used. They were kept on unimproved pasture while the experiments continued over a 2-year period.
Immunization
Immunogen (1·5 mg/sheep, except where otherwise indicated) was dispersed in the adjuvant solution (3 ml), suspension (3 ml) or emulsion (4 ml) by brief treatment in an homogenizer (Ultraturrax, Janke and Kunkel KG, Breisgau). The insoluble poly(styrene-maleic anhydride) copolymer (PSM) was used as a dispersion in sterile saline. The soluble sodium poly(styrene-maleate) (SPSM) was an appropriate dilution of the described preparation. The amounts of these copolymers that were used are reported separately for each experiment.
Except where variations are noted: (i) the immunogen-adjuvant compositions were given to each animal via the intramuscular (i.m., I ml to each hind leg) and subcutaneous (s.c.) routes (I ml distributed over six lumbar sites) and (ii) B. pertussis vaccine (0·5 ml, i.m. hind leg) was also administered separately. The first booster immunization with the same dose and by the same route was given 28 days post -primary; other boosters are reported separately for each experiment. Reference groups for each experiment were immunized with their respective immunogens (1·5 mg/sheep) in FCA emulsion (3 mllsheep) in the same manner, to provide a standard treatment for the comparison of each immunogen. The different immunization treatments are summarized in Table I .
Serum
Blood (10-15 ml) was withdrawn by syringe from the jugular vein at 28 days post-primary and 7 days post-booster immunization. It was kept at ambient temperature (1-4 h) and at 4°C (16 h) after which serum was collected and stored below -10°C until required for analysis.
Measurement and Definition of Testosterone Antibody Titre
An adaption of a published method (Schiller and Brammal 1974) employing PEG to separate bound and free steroid was used. Sera (0' 1 ml) were serially diluted with gelatin buffer and to the diluted serum (0'3 ml) was added 225 Bq eH]testosterone in gelatin buffer (0·1 ml). The mixture was incubated at 4°C for 16 h, mixed with 1% (w/v) BI'G in gelatin buffer (0'1 ml) and 22% (w/v) PEG in O'OS M phosphate buffer, pH 7·4 (0'9 ml). After being shaken in a Vortex mixer, the viscous solution was centrifuged (4°C, 2000 g, 20 min) and the supernatant decanted for measurement of unbound steroid. Antibody titre was taken as that dilution of antiserum that bound SO% of the maximum amount of labelled steroid that could be bound by the antiserum. Titre values are expressed in the tables as mean 10gIO reciprocal antibody titre.
Sensitivity of Antibody to 2-Mercaptoethanol
A solution of the antiserum (50 J.!I) in 2-mercaptoethanol (0'2 M, 50 J.!I) was incubated at 37°C (30 min). Serial dilutions were then made with O'OS M phosphate buffer (pH 7'4) containing 0·1 M 2-mercaptoethanol prior to determination of residual antibody titre.
Preparation of Poly(Styrene-Maleic Anhydride)
A deoxygenated, nitrogen-blanketed mixture of freshly distilled styrene (17' 4 g), maleic anhydride (16·4 g) and benzoyl peroxide (0'3 g) in dry benzene (140 ml) was heated with stirring, under reflux at 60°C. After a short induction period the exothermic reaction commenced, with precipitation of the benzene-insoluble polymer. The reaction mixture was maintained at 80-8SoC for 4 h, then filtered, and the insoluble product suspended in dry toluene (200 ml). This suspension was heated on a steam bath for an additional 2 h, then refiltered. The solid product was washed with light petroleum (b.p. 60-80°C) then dried at 80°CI2 kPa for 24 h, yielding poly(styrene-maleic anhydride) (31' S g) having viscosityaverage molecular weight of 480000 (hemi-ethyl ester, [11] = 125'3 ml/g in dioxan at 2S·0°C).
Preparation of Sodium Poly(Styrene-Maleate)
The poly(styrene-maleic anhydride) copolymer (3 g) suspended in distilled water (80 ml) was treated with 1 M sodium hydroxide (S ml) and heated on a steam bath (2 h). After cooling, the viscous solution obtained was adjusted to pH 7 and diluted to 100 ml to yield a solution of sodium poly(styrene-maleate) (39 mg/ml).
Statistical Analysis
For each experiment significance tests of differences between groups, between primary, secondary and tertiary booster immunizations and the interaction between groups and booster immunizations were performed by hierarchical analysis of variance. The analyses were computed for the treatment structure where levels of booster immunizations were regarded as being nested within each group. Prior to analysis the data were logarithmically transformed to stabilize variance heterogeneity. Conservative pairwise comparisons of means were subsequently performed by Tukey's test with ranges as for Student's t-test. Only those experimental groups that gave a measurable antibody response were included in the statistical analysis.
Experiment 1
Effect of PSM copolymer dose on antibody response Nine groups of five Corriedale ewes were used. Of eight experimental groups three were immunized with T -3-CMO-BSA and either 3, 10 or 30 mg of PSM copolymer together with O' S ml B. pertussis vaccine. A further three groups were immunized in the same manner but without B. pertussis. Two groups received immunogen alone in saline, with or without B. pertussis and there was one reference group which was immunized with FCA. All sheep received a booster immunization 28 days post-primary; selected groups that responded to the first booster were given a second at S8 days post-primary (see Table I ).
Experiment 2 Effect of PSM copolymer dose on antibody response
Six groups of four Corriedale ewes were used. Of five experimental groups four were immunized with T-3-CMO-BSA and either 3'9, 13, 39 or 130 mg of the soluble SPSM copolymer (equivalent to 3, 10, 30 and 100 mg respectively of PSM). One group was immunized with the immunogen and PSM and SPSM at separate sites as follows: PSM (15 mg) with immunogen (0·75 mg) in saline (1'5 ml) was administered to the left side of the sheep (1 ml, i.m., left leg; 0·5 ml 3 s.c. sites, left lumbar region). SPSM (19' 5 mg) with antigen (0'75 mg) in distilled water (1. 5 ml) was similarly administered to the right side. There was one reference group. The first booster immunization was given 28 days postprimary. Groups treated with the two highest levels of copolymer were given a second booster, 78 days post-primary.
Experiment 3 Effect of immunization route and PSM-SPSM on antibody response
Four groups of six Corriedale ewes were immunized using a T-3-CMO-HSA immunogen. One group injected intraperitoneally (i.p.) at one site, was given SPSM copolymer (78 mg/sheep). A second group was given SPSM copolymer (78 mg/sheep) by the i.m.ls.c. route. The third group was given PSM copolymer (30 mg/sheep) dispersed in a solution containing SPSM copolymer (39 mg/sheep, i.m.ls.c.) . The fourth was a reference group. Booster immunizations were given at 28 days and 56 days post-primary.
Experiment 4 Effect of SPSM copolymer with increased immunogen dose or with [FA on antibody response
Six groups of three Merino wethers were immunized with a T-3-CMO-BSA conjugate. Three groups received 1· 5,4' 5 and 13· 5 mg immunogen per sheep respectively with SPSM copolymer in aqueous solution (3 ml). Two groups received 1· 5 and 4· 5 mg immunogen per sheep respectively with SPSM copolymer in aqueous solution (2 ml) that was emulsified with IFA (2 ml) (2 by 1· 5 ml, i.m., 1 ml, six s.c. sites). All copolymer-treated sheep were given 78 mg SPSM. One group was for reference. A booster immunization was given to all groups 28 days post-primary.
Experiment 5
Ovulation response in testosterone-immune merino ewes Forty Merino ewes (5 yr) were randomized into two groups and kept jointly at pasture. Twenty ewes were immunized with a T-3-CMO-HSA conjugate (1. 5 mg/ewe) and SPSM copolymer (100 mg/ewe) with an interval of 28 days between primary and booster treatments. The remaining 20 ewes were untreated controls. On the day of booster immunization all ewes were submitted to oestrous cycle synchronization by intravaginal insertion of a progestagen sponge (Repromap, Upjohn Pty. Ltd). Twelve days post-booster the sponges were removed and four vasectomized rams fitted with marking crayons were introduced to the flock. Twenty-one days post-booster the ovulation rate in control and immune flocks was determined by laparoscopy under xylocaine anaesthesia and oestrus marks were recorded.
Results
A summary of the experimental procedures used in experiments 1-4 is given in Table 1 .
Experiment 1
As expected, immunogen administered alone in saline or with B. pertussis failed to produce a detectable titre after the booster. Similarly, at the lowest doses of PSM copolymer (3 or 10 mg) primary or secondary antibody responses were not observed. These data have been omitted from Table 2 . At a PSM dose of 30 mg no primary but a weak secondary response was obtained that was significantly lower (P < o· 01) than the reference group (Table 2 ). The tertiary response, i.e. that following a second booster immunization of this group was similar to the secondary testosterone antibody titre. There was no significant effect on titre response attributable to the B. pertussis vaccine. A Titre is mean 10glO reciprocal antibody titre. Standard error of the difference between any two means is 0·76 except within-treatment groups where it is 0·26. B Second booster given 58 days post-primary.
C Differences significant at P < 0·01 compared with other treatments in the same column.
Experiment 2
Sheep receiving 3· 9 mg SPSM failed to respond to the immunization; at 13 mg SPSM only a weak secondary response was detectable. These data have been omitted from Table 3 . The secondary responses due to 39 or 130 mg of SPSM were not significantly different but both were lower (P < 0·01) than those of the reference group (Table 3) . Secondary responses decreased substantially within 43 days of the booster. Tertiary responses were similar to secondaries and likewise had declined within 27 days.
When sheep were immunized by administration of PSM and SPSM at separate sites, the secondary antibody response tended to exceed that potentiated by an equivalent amount of SPSM and it was not significantly different from the reference group. However, tertiary responses following this joint copolymer administration were significantly lower (P < 0'01) than the reference group. D Differences significant at P < 0·01 compared with the 39 and 130 mg treatments in the same column.
E Differences significant at P < 0·01 compared with all other treatments in the same column.
Experiment 3
All but one ewe in the group immunized intraperitoneally failed to produce a detectable secondary antibody response. In contrast, when the SPSM was given by the usual i.m.ls.c. route, the expected secondary responses were observed in all animals (Table 4 ). There was no advantage when SPSM was used in admixture with PSM. All secondary, polymer-potentiated responses were significantly lower than the corresponding reference group (P < 0'01).
Experiment 4
Comparison of the reference groups in these studies indicates that the immunogenicity of the conjugate used in experiment 4 exceeded that used elsewhere by an order of magnitude approximately (Table 5 ). In consequence a measurable primary response occurred in all groups but was smaller in each of the copolymertreated groups than in the reference group (P < 0'01). None of the copolymerpotentiated primary responses were· significantly different from each other.
There was a clear trend for the secondary copolymer-potentiated responses to diminish with increasing immunogen dose, a lower response (P < 0·05) occurring at the highest level of immunogen. This suggests that, for sheep, an immunizing dose of 1 ·5-4·5 mg of conjugate may be near optimal for SPSM. When used as A Titre is mean loglO reciprocal antibody titre. Standard error of the difference between any two means is 0·28 except within-treatment groups when it is 0·10. B Second booster given 56 days post-primary. C,D,E Treatments within columns without a common superscript differ significantly an emulsion with IF A, responses due to the copolymer did not differ from those produced by corresponding SPSM solutions. Within 5 weeks of the booster immunization the antibody titre in the copolymer treated groups appeared to be declining whereas that in the reference group was maintained.
The mercaptoethanol susceptibility of copolymer-and FCA-potentiated, testosterone-binding antibody produced in this experiment proved to be high. In the former case only 5-10% and in the latter 10-20% of the antibody titre remained after treatment of the antiserum with the thiol reagent. 
Experiment 5
Copolymer-potentiated testosterone immunity in the Merino ewe increased the incidence of multiple ovulations and the ovulation rate in the treated ewes, compared to their controls (Table 6 ). There were no effects on oestrous behaviour.
Discussion
There are few adjuvants suitable for use with steroid-protein immunogens other than those having adverse tissue reactions associated with oil-based adjuvants such as FCA. Thus new, innocuous but effective adjuvants are much sought after and have potential applications in animal productivity research. The report (Wieczorek et al. 1975 ) that a synthetic poly(styrene-maleic anhydride) copolymer had immunoadjuvant activity in rodents stimulated the present investigation of its biological activity in a ruminant species.
The present research has explored the effects in ewes actively immunized against testosterone-serum albumin conjugates of: (i) copolymer dose; (ii) soluble and insoluble copolymers; (iii) immunization route; and (iv) dose of immunogen.
In experiment 1, PSM stimulated only a weak anti-testosterone antibody response and several explanations may account for this observation. PSM is a relatively insoluble copolymer anhydride and a possible explanation for its low activity may reside in its particle-size distribution. Others have shown that for insoluble polyacrylates, immunoadjuvant activity was a function of particle size (Kreuter and HaenzeI1978) . Alternatively it may have been that immunoadjuvant activity resulted from slow hydrolysis of PSM copolymer in vivo to a soluble polyanion. For this reason the solubilized sodium form of the copolymer (SPSM) was formed in vitro and was investigated in experiment 2. However, at dose rates up to 130 mg the change in the physical nature of the copolymer had no effect on its ability to potentiate antibody formation. Nevertheless, with SPSM individual animal responses tended to be more uniform than those obtainable with PSM. The anamnestic effect was small with tertiary responses being of the same order as secondary responses.
Immunization of the sheep by the intraperitoneal route with SPSM was ineffective (expt 3) and this result is contrary to previous experience with the mouse using red blood cells antigen (Wieczorek etal. 1975) . The development of an SPSM-potentiated primary testosterone antibody response proved to be strongly dependent on the immunogenicity of the conjugate used. Although separate immunogens were used in experiments 1-3 they were similarly immunogenic as judged by the FCA-stimulated responses and none yielded detectable primary antibody with the copolymer. Experiment 4 demonstrated that with a sufficiently immunogenic conjugate both a primary and a generally high secondary hapten-binding antibody response can be induced with SPSM. To obtain information about the testosterone-specific immunoglobulin subclass potentiated by the polyanion, sensitivity of the antibody titre to 2-mercaptoethanol was studied. The observed decrease of 90-95% in antibody titre following treatment of the serum with mercaptoethanol indicates a preponderance of IgM in the response induced by SPSM, an effect that was also noted for FCApotentiated antibody. Overall the SPSM copolymer-potentiated antibody titre responses are similar to those that can be obtained with the polycation adjuvant, DEAE-dextran, where 10glO reciprocal titres of about 2·3-3·5 are common. Such moderate titres are in fact critical to the conversion of increased ovulation rates to increase lambing percentages in steroid-immune ewes (Cox et at. 1982) .
The similarity between the two polyelectrolyte adjuvants also extends to the ovulatory response in the immune ewe. In experiment 5 the ovulation rate increase of 0·45 eggs per ewe in testosterone-immunized ewes is consistent with previous data in the field where DEAE-dextran was used as immunoadjuvant (Cox et at. 1982) and with the antibody titre achieved. With respect to the general suitability of the synthetic copolymer for animal immunizations, no overtly toxic symptoms have been observed in sheep given up to 300 mg PSM or 130 mg SPSM.
The present experiments have demonstrated that the synthetic poly(styrene-maleic anhydride) copolymer, preferably in its water-soluble form, has immunoadjuvant activity in the sheep as well as that reported in rodents. Further, the copolymer will potentiate a hapten-specific antibody response, a characteristic that was not investigated in previous work (Wieczorek et at. 1975) . Nevertheless, the response is significantly weaker and declines more rapidly than that due to FCA. These characteristics point to the possible use of the polyanion in studies where specifically weak antihapten antibody titres are of interest for relatively short periods.
